NEW YORK (GenomeWeb) – Cancer Genetics announced today that it has received special 510(k) clearance from the US Food and Drug Administration for its Tissue of Origin (TOO) gene expression test.
NEW YORK (GenomeWeb) – Cancer Genetics announced today that it has received special 510(k) clearance from the US Food and Drug Administration for its Tissue of Origin (TOO) gene expression test.
...and receive Daily News bulletins.
Already have a GenomeWeb or 360Dx account?
Login Now.
Don't have a GenomeWeb or 360Dx account?
Register for Free.
Privacy Policy. Terms & Conditions. . Copyright © 2021 GenomeWeb, a business unit of Crain Communications. All Rights Reserved.